Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

05 Mar 2017 - 09 Mar 2017
20 Mar 2017 - 23 Mar 2017

Actin-Binding Surface on Vinculin Mediates Mechanical Aspects of Cell Movement

By BiotechDaily International staff writers
Posted on 07 May 2014
Image: Proteins actin and vinculin bind together at a site identified by researchers at the University of North Carolina. The interaction of these proteins plays an important role in cell movement (Photo courtesy of the University of North Carolina).
Image: Proteins actin and vinculin bind together at a site identified by researchers at the University of North Carolina. The interaction of these proteins plays an important role in cell movement (Photo courtesy of the University of North Carolina).
ADVERTISEMENT
SARTORIUS AG
A team of cell biologists has obtained data that shows how two proteins, vinculin and actin, function in concert to regulate cell morphology, motility, and mechanotransduction (the conversion of mechanical signals into electrical or chemical signals) and play a critical role in metastasis.

Vinculin is a cytoskeletal scaffold protein essential for embryogenesis and cardiovascular function. It localizes to focal adhesions and adherens junctions, where it connects cell surface receptors to the actin cytoskeleton. While vinculin interacts with many adhesion proteins, its interaction with filamentous actin regulates cell morphology, motility, and mechanotransduction.

Investigators at the University of North Carolina (Chapel Hill, USA) used negative-stain electron microscopy, discrete molecular dynamics techniques, and mutagenesis to develop a new model to explain the interaction between vinculin and actin. A major breakthrough in this effort was the development of mutated versions of vinculin that disrupted the actin/vinculin interaction in specific and traceable fashion.

Results published in the April 2014 online edition of the journal Structure revealed that actin-binding deficient vinculin variants expressed in vinculin knockout fibroblasts failed to correct cell-spreading defects and reduced cellular response to external force. These findings highlighted the importance of this actin-binding surface and provided the molecular basis for elucidating additional roles of this interaction, including actin-induced conformational changes that promoted actin bundling.

“Our data suggest that there is a face on the vinculin tail that has been ignored by the previous model, and that it is very important,” said first author Peter Thompson, a graduate researcher at the University of North Carolina. “In your cardiovascular system – your heart and arteries – the cells that form these organs need to stick together tightly. They do these in part by forming cell-to-cell adherens junctions. Vinculin creates a critical physical link between the actin cytoskeleton and these junctions. If you disrupt that, the hypothesis is that cells no longer respond appropriately to force and the organ suffers.”

“Our data supported a unique surface that was important for actin binding,” said senior author Dr. Sharon Campbell, professor of biochemistry and biophysics at the University of North Carolina. “Identification of this actin binding surface on vinculin has enabled us to dissect how this critical interaction controls how cells respond to force and move. This in turn, will help us better understand how dysregulation leads to disease.”

Related Links:
University of North Carolina



Channels

Drug Discovery

view channel
Image: The experimental drug NGI-1 slows cancer growth by blocking glycosylation of the epidermal growth factor receptor (EGFR), which is shown in the above diagram (Photo courtesy of Wikimedia Commons).

Experimental Drug Slows Lung Cancer Growth by Blocking Protein Glycosylation

An interesting new experimental anti-cancer drug slows growth of certain lung tumor cells by preventing the glycosylation of critical cell surface receptor proteins. Asparagine (N)-linked glycosylation... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Business

view channel

Collaborative Agreement to Aid in Setting Guidelines for Evaluating Potential Ebola Therapy

Cooperation between an Israeli biopharmaceutical company and medical branches of the US government is designed to set ground rules for continued evaluation of an experimental therapy for Ebola virus disease. RedHill Biopharma Ltd. (Tel Aviv, Israel), a biopharmaceutical company primarily focused on development and c... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.